急性心肌梗死合并心源性休克患者临床治疗策略

Clinical treatment strategy for patients with acute myocardial infarction complicated with cardiogenic shock

心源性休克是急性心肌梗死患者死亡的主要原因之一,现阶段临床治疗急性心肌梗死合并心源性休克患者多采用急诊介入手术方式。在手术治疗的同时,通过药物辅助治疗能改善患者临床症状,促进患者血流灌注尽早恢复,提升临床治疗效果,降低临床炎性症状及出血等风险,能在一定程度上维持患者的平均动脉压,保障其生命安全。本研究针对急性心肌梗死合并心源性休克现阶段治疗策略、药物治疗方案及多器官功能不全综合征防治措施等相关内容予以综述,希望为临床治疗及研究提供方向。

Cardiogenic shock is one of the main causes of death in patients with acute myocardial infarction. At present, patients with acute myocardial infarction and cardiogenic shock are treated with emergency interventional surgery. At the same time of surgical treatment, drug .assisted treatment improved the clinical symptoms of patients, which included promoting the early recovery of blood perfusion. reducing the risk of clinical inflammatory symptoms and bleeding, and maintain the average artery of patients. This study reviewed the current treatment strategies, drug treatment programs and prevention and treatment measures for multiple organ dysfunction syndrome in acute myocardial infarction with cardiogenic shock. and provided direction for clinical treatment and research.